Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hybrid closed-loop insulin therapy has shown promise for management of type 1 diabetes during pregnancy; however, its efficacy is unclear. METHODS: In this multicenter, controlled trial, we randomly assigned pregnant women with type 1 diabetes and a glycated hemoglobin level of at least 6.5% at nine sites in the United Kingdom to receive standard insulin therapy or hybrid closed-loop therapy, with both groups using continuous glucose monitoring. The primary outcome was the percentage of time in the pregnancy-specific target glucose range (63 to 140 mg per deciliter [3.5 to 7.8 mmol per liter]) as measured by continuous glucose monitoring from 16 weeks' gestation until delivery. Analyses were performed according to the intention-to-treat principle. Key secondary outcomes were the percentage of time spent in a hyperglycemic state (glucose level >140 mg per deciliter), overnight time in the target range, the glycated hemoglobin level, and safety events. RESULTS: A total of 124 participants with a mean (±SD) age of 31.1±5.3 years and a mean baseline glycated hemoglobin level of 7.7±1.2% underwent randomization. The mean percentage of time that the maternal glucose level was in the target range was 68.2±10.5% in the closed-loop group and 55.6±12.5% in the standard-care group (mean adjusted difference, 10.5 percentage points; 95% confidence interval [CI], 7.0 to 14.0; P<0.001). Results for the secondary outcomes were consistent with those of the primary outcome; participants in the closed-loop group spent less time in a hyperglycemic state than those in the standard-care group (difference, -10.2 percentage points; 95% CI, -13.8 to -6.6); had more overnight time in the target range (difference, 12.3 percentage points; 95% CI, 8.3 to 16.2), and had lower glycated hemoglobin levels (difference, -0.31 percentage points; 95% CI, -0.50 to -0.12). Little time was spent in a hypoglycemic state. No unanticipated safety problems associated with the use of closed-loop therapy during pregnancy occurred (6 instances of severe hypoglycemia, vs. 5 in the standard-care group; 1 instance of diabetic ketoacidosis in each group; and 12 device-related adverse events in the closed-loop group, 7 related to closed-loop therapy). CONCLUSIONS: Hybrid closed-loop therapy significantly improved maternal glycemic control during pregnancy complicated by type 1 diabetes. (Funded by the Efficacy and Mechanism Evaluation Program; AiDAPT ISRCTN Registry number, ISRCTN56898625.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Only one AID system is approved for use during pregnancy, and it has been shown to improve time in the target glucose range of 3•5-7•8 mmol/L without increasing the risk of hypoglycaemia.104”
From The future of type 1 diabetes therapy (2025) · cites this paper as [104]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Improvements have been especially notable in vulnerable populations, such as young children 103 and pregnant women with type 1 diabetes.104”
From The future of type 1 diabetes therapy (2025) · cites this paper as [104]
In the citing paper
“The secondary outcomes were also met, with less time spent above range (>140 mg/dL) in the AID group, greater overnight time in target range, and lower A1C (236).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [236]
In the citing paper
“Recent data have shown the clinical benefits and safety of AID use, even though only one study used an AID system with a pregnancyspecific glycemic target.”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [236]
In the citing paper
“The primary outcome of time spent in the pregnancy-specific target range of 63-140 mg/dL was found to be 10.5% higher in the AID group versus standard care (P < 0.001).”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [236]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Self-citationFeig, D. S., Donovan, L. E., Corcoy, R., Murphy, K. E., Amiel, S. A., Hunt, K. F., Asztalos, E., Barrett, J. F. R., Sanchez, J. J., de Leiva, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32400-5 · Cited by 803
Self-citationEvers, I. M., de Valk, H. W., & Visser, G. H. A. (2004) · BMJ · doi:10.1136/bmj.38043.583160.ee · Cited by 775
Per-Protocol Analyses of Pragmatic Trials
Hernán, M. A., & Robins, J. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmsm1605385 · Cited by 660
Phillip, M., Nimri, R., Bergenstal, R. M., Barnard-Kelly, K., Danne, T., Hovorka, R., Kovatchev, B. P., Messer, L. H., Parkin, C. G., Ambler-Osborn, L., et al. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac022 · Cited by 443
Self-citationMurphy, H. R., Howgate, C., O'Keefe, J., Myers, J., Morgan, M., Coleman, M. A., Jolly, M., Valabhji, J., Scott, E. M., Knighton, P., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30406-x · Cited by 346
Self-citationClosed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes
Stewart, Z. A., Wilinska, M. E., Hartnell, S., Temple, R. C., Rayman, G., Stanley, K. P., Simmons, D., Law, G. R., Scott, E. M., Hovorka, R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602494 · Cited by 279
Self-citationRandomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes
Ware, J., Allen, J. M., Boughton, C. K., Wilinska, M. E., Hartnell, S., Thankamony, A., de Beaufort, C., Schierloh, U., Fröhlich-Reiterer, E., Mader, J. K., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2111673 · Cited by 222
Self-citationTrial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes
Wadwa, R. P., Reed, Z. W., Buckingham, B. A., DeBoer, M. D., Ekhlaspour, L., Forlenza, G. P., Schoelwer, M., Lum, J., Kollman, C., Beck, R. W., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2210834 · Cited by 191
Self-citationStewart, Z. A., Wilinska, M. E., Hartnell, S., O’Neil, L. K., Rayman, G., Scott, E. M., Barnard, K., Farrington, C., Hovorka, R., & Murphy, H. R. (2018) · Diabetes Care · doi:10.2337/dc17-2534 · Cited by 168
Self-citation
Cited by
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s015 · Cited by 252
Benhalima, K., Beunen, K., Van Wilder, N., Ballaux, D., Vanhaverbeke, G., Taes, Y., Aers, X.-P., Nobels, F., Marlier, J., Lee, D., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00089-5 · Cited by 131
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Brown, F. M., ChallaSivaKanaka, S., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s015 · Cited by 169
Di Molfetta, S., Di Gioia, L., Caruso, I., Cignarelli, A., Green, S. C., Natale, P., Strippoli, G. F. M., Sorice, G. P., Perrini, S., Natalicchio, A., et al. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3842 · Cited by 76
Ebekozien, O., Fantasia, K., Farrokhi, F., Sabharwal, A., & Kerr, D. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15470 · Cited by 70
“111”
Digital Technology for Diabetes
Hughes, M. S., Addala, A., & Buckingham, B. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2215899 · Cited by 59
The role of automated insulin delivery technology in diabetes
Boughton, C. K., & Hovorka, R. (2024) · Diabetologia · doi:10.1007/s00125-024-06165-w · Cited by 57
Self-citationRoos, T., Hermanns, N., Groß, C., Kulzer, B., Haak, T., & Ehrmann, D. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102852 · Cited by 62
Wyckoff, J., Lapolla, A., Asias-Dinh, B. D., Barbour, L. A., Brown, F. M., Catalano, P. M., Corcoy, R., Renzo, G. C. D., Drobycki, N., Kautzky‐Willer, A., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf288 · Cited by 59
Listening to Women: Experiences of Using Closed-Loop in Type 1 Diabetes Pregnancy
Lawton, J., Kimbell, B., Closs, M., Hartnell, S., Lee, T., Dover, A. R., Reynolds, R. M., Collett, C., Barnard-Kelly, K. D., Hovorka, R., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0323 · Cited by 56
Self-citationKovatchev, B. P., Colmegna, P. H., Pavan, J., C., J. L. D., Villa-Tamayo, M. F., Koravi, C. L. K., Santini, G., Alix, C., Stumpf, M. M., & Brown, S. A. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01679-y · Cited by 64
The future of type 1 diabetes therapy
Ziegler, A.-G., Cengiz, E., & Kay, T. W. H. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01438-2 · Cited by 42
Polsky, S., Buschur, E., Dungan, K., Garcetti, R., Nease, E., Malecha, E., Bartholomew, A., Johnson, C., Pyle, L., & Snell-Bergeon, J. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0012 · Cited by 39
Towards intelligent and miniaturized drug delivery devices
Wei, X., Buse, J. B., Chen, H., Desai, T. A., Stevens, M. M., Traverso, G., Langer, R., & Gu, Z. (2026) · Nature · doi:10.1038/s41586-026-10221-3 · Cited by 48
Stahl‐Pehe, A., Mashhadi, N. S., Wirth, M., Schlesinger, S., Kuß, O., Holl, R. W., Bächle, C., Warz, K.-D., Bürger-Büsing, J., Spörkel, O., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103190 · Cited by 42
Beunen, K., Gillard, P., Wilder, N. V., Ballaux, D., Vanhaverbeke, G., Taes, Y., Aers, X.-P., Nobels, F. R. E., Huffel, L. V., Marlier, J., et al. (2024) · Diabetes Care · doi:10.2337/dc24-1320 · Cited by 38
Closed-Loop Insulin Delivery in Type 1 Diabetes in Pregnancy: The CIRCUIT Randomized Clinical Trial
Donovan, L., Lemieux, P., Dunlop, A. D., Yamamoto, J. M., Murphy, H. R., Simmons, D. S., Bell, R. C., Chaput, K. H., Benham, J. L., Ross, G. P., et al. (2025) · JAMA · doi:10.1001/jama.2025.19578 · Cited by 38
Self-citationAsgharzadeh, A., Patel, M., Connock, M. J., Damery, S. L., Ghosh, I., Jordan, M., Freeman, K., Brown, A., Court, R. A., Baldwin, S., et al. (2024) · Health Technology Assessment · doi:10.3310/jypl3536 · Cited by 37
Benhalima, K., Durnwald, C. P., Sweeting, A., Adams, D., Addala, A., Battelino, T., Bergenstal, R. M., Carlson, A. L., Donovan, L., Franco, D. R., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00335-3 · Cited by 37
Self-citationClosed-loop systems: recent advancements and lived experiences
Kadiyala, N., Hovorka, R., & Boughton, C. K. (2024) · Expert Review of Medical Devices · doi:10.1080/17434440.2024.2406901 · Cited by 33
Self-citationWang, Y., Lu, J., Yu, J., Ni, J., Wang, M., Lu, W., Zhu, W. M., Guo, J., Bao, Y., & Zhou, J. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16143 · Cited by 30
Automated Insulin Delivery for Pregnant Women With Type 1 Diabetes: Where Do We Stand?
Benhalima, K., JENDLE, J. H., Beunen, K., & Ringholm, L. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231223934 · Cited by 28
Wyckoff, J., Lapolla, A., Asias-Dinh, B. D., Barbour, L. A., Brown, F. M., Catalano, P. M., Corcoy, R., Renzo, G. C. D., Drobycki, N., Kautzky‐Willer, A., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf116 · Cited by 30
Development and Future of Automated Insulin Delivery (AID) Systems
Garg, S. K., & MCVEAN, J. J. F. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0467 · Cited by 28
Lee, T., Collett, C., Bergford, S., Hartnell, S., SCOTT, E. M., Lindsay, R. S., Hunt, K. F., McCance, D. R., Reynolds, R. M., Wilinska, M. E., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00340-1 · Cited by 27
Self-citationAnandhakrishnan, A., & Hussain, S. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15920 · Cited by 28
Burk, J., Ross, G. P., Hernandez, T. L., Colagiuri, S., & Sweeting, A. (2025) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2025.04.010 · Cited by 26
Battarbee, A. N., Durnwald, C. P., Yee, L. M., & Valent, A. M. (2024) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005669 · Cited by 21
Stephansson, O., & Sandström, A. (2024) · Journal of Internal Medicine · doi:10.1111/joim.13823 · Cited by 21
Szmuilowicz, E. D., Barbour, L. A., Brown, F. M., Durnwald, C. P., Feig, D. S., O’Malley, G., Polsky, S., & Aleppo, G. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241239341 · Cited by 23
Technology advances in diabetes pregnancy: right technology, right person, right time
McLean, A., Maple-Brown, L. J., & Murphy, H. R. (2024) · Diabetologia · doi:10.1007/s00125-024-06216-2 · Cited by 22
Self-citationIbrahim, M. A., Ba-Essa, E. M., Ahmed, A., Ahmad, E., Annabi, F. A., Chaabane, H., Tuccinardi, D., Davies, M. J., Domenico, F. D., Eckel, R. H., et al. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70057 · Cited by 21
Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems
Jacobs, P. G., Levy, C. J., Brown, S. A., Riddell, M. C., Çınar, A., Boughton, C. K., Breton, M. D., Dassau, E., Forlenza, G. P., Henderson, R. J., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251338754 · Cited by 24
Self-citationKim, J. Y., Jin, S.-M., Kang, E. S., Kwak, S. H., Yang, Y., Yoo, J. H., Bae, J. H., Moon, J. S., Jung, C. H., Bae, J. C., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06155-y · Cited by 17
Søholm, J. C., Nørgaard, S. K., Nørgaard, K., Clausen, T. D., Damm, P., Mathiesen, E. R., & Ringholm, L. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0583 · Cited by 16
Munda, A., Kovacic, C., & Barlovič, D. P. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108795 · Cited by 16
Tanenbaum, M. L., COMMISSARIAT, P. V., Wilmot, E. G., & Lange, K. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241275963 · Cited by 15
Pemberton, J. S., Andrews, R. C., Barnard-Kelly, K. D., Battelino, T., Danne, T., Heinemann, L., Kar, P., Lumb, A. N., Maahs, D. M., Mader, J. K., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70460 · Cited by 17
Self-citationStamati, A., & Christoforidis, A. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02446-x · Cited by 16
Automated Insulin Delivery in Pregnancies Complicated by Type 1 Diabetes
Benhalima, K., & Polsky, S. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251323614 · Cited by 17
Lee, T., Collett, C., Bergford, S., Hartnell, S., SCOTT, E. M., Lindsay, R. S., Hunt, K. F., McCance, D. R., Barnard-Kelly, K. D., Rankin, D., et al. (2023) · Efficacy and Mechanism Evaluation · doi:10.3310/wchz4201 · Cited by 20
Self-citationAtta, N., Ezeoke, A., Petry, C. J., Kusinski, L. C., & Meek, C. L. (2024) · Diabetes Care · doi:10.2337/dc24-0725 · Cited by 14
Use of continuous glucose monitoring and hybrid closed‐loop therapy in pregnancy
Benhalima, K., & Yamamoto, J. M. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15999 · Cited by 15
Hughes, M. S., Pasquel, F. J., Davis, G. M., Lal, R., Buckingham, B. A., Boughton, C. K., Brown, S. A., & Bally, L. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0343 · Cited by 14
Szmuilowicz, E. D., Durnwald, C. P., & Feig, D. S. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251330651 · Cited by 13
A Diabetes Pregnancy Technology Roadmap: The 2023 Norbert Freinkel Award Lecture
Murphy, H. R. (2024) · Diabetes Care · doi:10.2337/dci23-0067 · Cited by 12
Self-citationUse of Automated Insulin Delivery in Pregnancies Complicated by Type 1 Diabetes
Chillakanti, M., Young, E., Hopcroft, A., Bellini, N. J., Smith, J. A., & Isaacs, D. M. (2024) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2024.20.2.14 · Cited by 11
Murrin, E. M., Saad, A. F., SULLIVAN, S. A., Millo, Y., & Miodovnik, M. (2024) · American Journal of Perinatology · doi:10.1055/a-2489-4462 · Cited by 13
Fresa, R., Bitterman, O., Cavallaro, V., Filippi, M. D., Dimarzo, D., Mosca, C., Nappi, F., Rispoli, M., & Napoli, A. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02315-z · Cited by 10
Wen, T., Friedman, A. M., Gyamfi‐Bannerman, C., Powe, C. E., Sobhani, N. C., Ramos, G. A., Gabbe, S. G., Landon, M. B., Grobman, W. A., & Venkatesh, K. K. (2024) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005667 · Cited by 11
Tumminia, A., Santoro, G. M., Oteri, V., Galeano, F., Baratta, R., Gullo, D., Frittitta, L., Sciacca, L., Moli, R. L., Piticchio, T., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112173 · Cited by 9
Case series of a hybrid closed loop therapy system used in pregnancy
Brigham, T. L., Klein, M. P., Snell‐Bergeon, J. K., & Polsky, S. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02469-4 · Cited by 9
Evolution of the Artificial Pancreas: Components and Integration—CGMs, Insulin, and AP Systems
Bergenstal, R. M., Heller, A., Breton, M. D., Vigersky, R. A., Brown, S. A., Forlenza, G. P., Sherr, J. L., Hovorka, R., Russell, S. J., Damiano, E. R., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251342239 · Cited by 10
Self-citationAzahaf, S., Beunen, K., Wilder, N. V., Ballaux, D., Vanhaverbeke, G., Taes, Y., Aers, X.-P., Nobels, F. R. E., Huffel, L. V., Marlier, J., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103106 · Cited by 10
Bismuth, É., Joubert, M., Renard, É., Tubiana‐Rufi, N., Chaillous, L., Bonnemaison, É., Hanaire, H. P., Coutant, R., Schaepelynck, P., Beltrand, J., et al. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101637 · Cited by 10
Goldberg, A., Wiberg‐Itzel, E., Tingström, J., & Ekéus, C. (2025) · Acta Paediatrica · doi:10.1111/apa.70230 · Cited by 8
Quirós, C., Wägner, A. M., Azriel, S., Soldevila, B., Beato-Víbora, P. I., Arranz, M. H., Nattero‐Chávez, L., César, M. J. P., Climent, E., Amigó, J., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251379488 · Cited by 10
Hwang, M., Rachim, V. P., Yoo, J., Lee, Y., & Park, S. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01994-4 · Cited by 13
Lei, M., Chen, D., Ling, P., Wang, C., Yang, D., Deng, H., Yang, X., Xu, W., & Yan, J. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15357 · Cited by 8
Klein, M. P., Brigham, T. L., Snell‐Bergeon, J. K., & Polsky, S. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241266850 · Cited by 8
Transitioning between automated insulin delivery systems: A focus on personalisation
Beato-Víbora, P. I., Chico, A. I., Moreno-Fernández, J., Azriel, S., Nattero‐Chávez, L., Mora, M. R. V., Alonso-Carril, N., Simó‐Servat, O., Aguilera, E., Reyes, L., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112070 · Cited by 8
Sibiak, R., Mantaj, U., Gutaj, P., Law, G. R., & Wender-Ożegowska, E. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111088 · Cited by 9
Resi, V., Bianchi, C., Burlina, S., Grancini, V., Manicardi, E., Masulli, M., Scarpitta, A. M., Sorice, G. P., & Fresa, R. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02592-2 · Cited by 7
Glucose Control During Labour and Delivery in Type 1 Diabetes – An Update on Current Evidence
Ringholm, L., Søholm, J. C., Pedersen, B. W., Clausen, T. D., Damm, P., & Mathiesen, E. R. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01563-1 · Cited by 8
Renard, É., Tubiana‐Rufi, N., Chaillous, L., Bonnemaison, É., Hanaire, H. P., Bismuth, É., Joubert, M., Coutant, R., Schaepelynck, P., Beltrand, J., et al. (2024) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2024.04.002 · Cited by 13
Buschur, E., Reedy, J., Berget, C., Barnard, J. G., Garcetti, R., Nease, E., Bartholomew, A. B. C., Johnson, C. A., Driscoll, K. A., Dungan, K. M., et al. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.01.005 · Cited by 7
Speight, J., Hermanns, N., Jensen, W., Kanc, K., Karagiannis, T., Law, M., Mocan, A., Rutters, F., Sturt, J. A., Zaccardi, F., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06840-0 · Cited by 15
Ling, P., Yang, D., Wang, C., Zheng, X., Luo, S., Yang, X., Deng, H., Xu, W., Yan, J., & Weng, J. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae291 · Cited by 6
One-year evaluation of automated insulin delivery systems in adults with type 1 diabetes
Pujante, P., García, A. V., Villa-Fernández, E., García‐Villarino, M., González‐Vidal, T., Díaz-Naya, L., Gutiérrez-Buey, G., Veiguela, B., Rivas‐Otero, D., Torre, E. L. M., et al. (2025) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1596188 · Cited by 6
Diabetes Mellitus in Pregnancy: Implications for Obstetric Anesthesia
Rogers, W. K., Chugaieva, I., Moheet, A. A., & Wernimont, S. A. (2025) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0001192196.21020.41 · Cited by 7
Automated Insulin Delivery for Type 1 Diabetes: Present and Future
Akcan, T., Lee, M. Y., Needleman, L., & Lal, R. (2025) · Diabetes Spectrum · doi:10.2337/dsi25-0003 · Cited by 6
Type 1 diabetes mellitus: a brave new world
Martens, P.-J., & Mathieu, C. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00936-y · Cited by 6
Suboptimally Controlled Diabetes in Pregnancy: A Review to Guide Antepartum and Delivery Management
Cate, J. J. M., Bloom, E. A., Chu, A., Bauer, S., Kuller, J. A., & Dotters-Katz, S. K. (2024) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000001270 · Cited by 7
Diabetes Technology Use in Special Populations: A Narrative Review of Psychosocial Factors
Hughes, M. S., Aleppo, G., Bally, L., Batista, A. F. M. B., Brown, S. A., Faulds, E. R., Gonder-Frederick, L. A., Isaacs, D. M., Kahkoska, A. R., Ortega, J., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241296853 · Cited by 6
The Latest Trends in the Management of Type 1 and Type 2 Diabetes Mellitus
DeClue, C. E., Gonzalez, M., Bradley, A. B., Leon, B. G. C., & Srivastava, G. (2024) · Endocrines · doi:10.3390/endocrines5040041 · Cited by 6
Registration and Real-Life Studies on Automated Insulin Delivery Systems
Aktürk, H. K., Brown, S. A., Beck, R. W., Sherr, J. L., Bergenstal, R. M., Kovatchev, B. P., Vigersky, R. A., Breton, M. D., Hovorka, R., Klonoff, D. C., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251334993 · Cited by 7
Self-citationRegistration and Real-Life Studies on Automated Insulin Delivery Systems
Aktürk, H. K., Brown, S. A., Beck, R. W., Sherr, J. L., Bergenstal, R. M., Kovatchev, B. P., Vigersky, R. A., Breton, M. D., Hovorka, R., Klonoff, D. C., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0130 · Cited by 6
Self-citationOne Size Does Not Fit All: The Need for Sex-Specific Precision Medicine in Diabetes Technology
Hossmann, S., Tan, S., Mader, J. K., Klonoff, D. C., Adams, D., Ballhausen, H., Bally, L., Balmer, M. L., Braunack-Mayer, V., Bonhoure, A., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251340673 · Cited by 6
Type 1 Diabetes and Pregnancy: Challenges in Glycemic Control and Maternal–Fetal Outcomes
Apata, T., Samuel, D., Valle, L., & Crimmins, S. D. (2024) · Seminars in Reproductive Medicine · doi:10.1055/s-0044-1791704 · Cited by 6
FIELD, C. P., Venkatesh, K. K., & Buschur, E. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251329288 · Cited by 5
Metabolic Models, in Silico Trials, and Algorithms
Çınar, A., Basu, A., Bequette, B. W., Breton, M. D., Buckingham, B. A., Cengiz, E., Cobelli, C., Dassau, E., Doyle, F. J., Fabris, C., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.18800.ac · Cited by 5
Self-citationResearch Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems
Jacobs, P. G., Levy, C. J., Brown, S. A., Riddell, M. C., Çınar, A., Boughton, C. K., Breton, M. D., Dassau, E., Forlenza, G. P., Henderson, R. J., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0129 · Cited by 7
Self-citationAgarwal, S., Demidowich, A. P., Soliman, D., Umpierrez, G. E., & Galindo, R. J. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251364276 · Cited by 7
Evolution of the Artificial Pancreas: Components and Integration—CGMs, Insulin, and AP Systems
Bergenstal, R. M., Heller, A., Breton, M. D., Vigersky, R. A., Brown, S. A., Forlenza, G. P., Sherr, J. L., Hovorka, R., Russell, S. J., Damiano, E. R., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.18801.rmb · Cited by 6
Self-citationRethinking control‐ IQ + technology: Simple strategies for easy optimization
Shah, V. N., Choudhary, P., Halperin, I. J., Rabbone, I., Zaharieva, D. P., & Messer, L. H. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70500 · Cited by 5
Citro, F., Bianchi, C., Nicolì, F., Aragona, M., Marchetti, P., Cianni, G. D., & Bertolotto, A. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110979 · Cited by 6
Demarcating the benefits of hybrid closed loop therapy in pregnant women with type 1 diabetes
Murphy, H. R., & SCOTT, E. M. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00104-9 · Cited by 5
Self-citationQuintanilha, M., Yamamoto, J. M., Aylward, B., Feig, D. S., Lemieux, P., Murphy, H. R., Sigal, R. J., Ho, J., Virtanen, H., Crawford, S. G., et al. (2024) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2024.08.005 · Cited by 5
Self-citationTahir, S., Naeem, S., Nayyab, I., Batool, A., Emeish, S., Hasan, I., Dhir, A., Shahid, J., Sheraz, M. A., Singh, J., et al. (2025) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2025.113969 · Cited by 5
Metabolic Models, in Silico Trials, and Algorithms
Çınar, A., Basu, A., Bequette, B. W., Breton, M. D., Buckingham, B. A., Cengiz, E., Cobelli, C., Dassau, E., Doyle, F. J., Fabris, C., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251338300 · Cited by 10
Self-citationPham, A. Q., Lingvay, I., Ahmadi, N., Santiago-Munoz, P. C., & Abreu, M. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112454 · Cited by 5
Technology Use and Glycemic Outcomes during Pregnancy with Type 1 Diabetes
Garg, S. K., & Polsky, S. (2023) · New England Journal of Medicine · doi:10.1056/nejme2310798 · Cited by 5
Feig, D. S., & SCOTT, E. M. (2023) · Diabetes Care · doi:10.2337/dci23-0079 · Cited by 5
Self-citationClosed-Loop, Artificial Intelligence-Based Decision Support Systems, and Data Science
Nimri, R., Phillip, M., Clements, M. A., & Kovatchev, B. P. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.8805.rev · Cited by 7
Sauer, S. M., Fulcher, I., Sanusi, A. A., & Battarbee, A. N. (2025) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2025.101669 · Cited by 4
Wang, Q., Li, X., Zhang, W., Wang, H., Tang, J., Ding, Y., Zheng, X., & Luo, S. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251350210 · Cited by 4
EndoCompass project: research roadmap for diabetes, obesity, and metabolism
Mathieu, C., Meireles, M., Pagotto, U., Wabitsch, M., Banerjee, I., Bartolomé, A., Battelino, T., Beck, J., Chiarelli, F., León, D. D. D., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf065 · Cited by 5
Royston, C., Bergford, S., Calhoun, P. M., Sibayan, J., Ruan, Y., Boughton, C. K., Wilinska, M. E., & Hovorka, R. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0298 · Cited by 4
Self-citationCitro, F., Bianchi, C., Belcari, T., Galleano, F., Venturi, C., Battini, L., Marchetti, P., Bertolotto, A., & Aragona, M. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241289957 · Cited by 5
Metadata
- Authors
- Lee, T. T. M., Collett, C., Bergford, S., Hartnell, S., Scott, E. M., Lindsay, R. S., Hunt, K. F., McCance, D. R., Barnard-Kelly, K., Rankin, D., Lawton, J., Reynolds, R. M., Flanagan, E., Hammond, M., Shepstone, L., Wilinska, M. E., Sibayan, J., Kollman, C., Beck, R., Hovorka, R., & Murphy, H. R.
- Affiliations
- University of East Anglia (GB)
- ORCID
- Lee, Tara T.M.
- Collett, Corinne
- Bergford, Simon
- Hartnell, Sara
- Scott, Eleanor M.
- Lindsay, Robert S.
- Hunt, Katharine F.
- McCance, David R.
- Barnard-Kelly, Katharine
- Rankin, David
- Lawton, Julia
- Reynolds, Rebecca M.
- Hammond, Matthew
- Shepstone, Lee
- Wilinska, Malgorzata E.
- Sibayan, Judy
- Kollman, Craig
- Beck, Roy
- Hovorka, Roman
- Murphy, Helen R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-10-26
- Volume
- 389
- Issue
- 17
- Pages
- 1566-1578
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4387357591
- Cited by
- 241
- References
- 23
- Citations by year
- 2026: 61 · 2025: 102 · 2024: 68 · 2023: 9
- FWCI
- 49.35
- Type
- journal article
- Language
- en
- Open access
- Licence
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (publishedVersion, cc-by)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Efficacy and Mechanism Evaluation Programme (NIHR EME reference 16/35/01)
- Juvenile Diabetes Research Foundation United States of America (#2-RSC-2019-828-M-N, #22-2013-266)
- Diabetes Research and Wellness Foundation (Sutherland-Earl Fellowship (reference SECF/21))
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 1 diabetes, pregnancy, artificial pancreas, continuous glucose monitoring, glycemic control, HbA1c, time in range, hyperglycemia, hypoglycemia, maternal safety, gestational diabetes management, severe hypoglycemia, neonatal outcomes, neonatal hypoglycemia
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Pregnancy, Pregnancy in Diabetics, Blood Glucose Self-Monitoring, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.